Clinical Nutrition Market worth over $76.1bn by 2027

Clinical Nutrition Market size is set to surpass USD 76.1 billion by 2027, according to a new research report by Global Market Insights Inc.

Growing percentage of female participation in the labor force in developing countries have opened-up new opportunities for the clinical nutrition market, as the demand for products compatible with working mothers schedule is increasing. Rising urbanization and growth of the middle-class consumers in emerging economies have augmented the demand for nutritious baby food. According to the United Nations Children’s Fund, poor nutrition to newborns in their early 1,000 days may lead to stunted growth and weakened cognitive ability. The increasing burden of malnutrition, growing prevalence of cancer disease, and high natality rate across the globe that needs administration of vital nutrients is expected to fuel the market growth.


Request Sample Buy NowInquiry Before Buying


Increasing premature birth rate is anticipated to propel the clinical nutrition market expansion

Growing premature birth rate is slated to foster the industry growth. The rising preterm births across the globe is one of the significant factors that is driving the demand for clinical nutrition products to meet the dietary requirements of infants. Additionally, the increasing prevalence of chronic disorders in the newborn is estimated to spur the market revenue over the forecast period. According to the World Health Organization, around 15 million neonates are born preterm worldwide. Similarly, in India, around 3.6 million infants are born premature and over 300,000 of these premature babies die every year owing to the nutrition related issues. As per the WHO, in 184 countries, the rate of premature birth ranges from 5% to 18% of infants born. Milk and soy-based products are widely used for babies as they provide extra calories, calcium, vitamins, and protein, thereby facilitating the market progression over the forecast period.

Growing awareness about clinical nutrition is expected to influence the market value

Global Clinical Nutrition Market, By Product

Get more details on this report - Request Free Sample PDF

The enteral nutrition segment in the clinical nutrition market is predicted to expand at 7.9% growth rate by 2027 led by the stimulation of intestinal blood flow, fewer complications in the process, prevents disuse atrophy, and improves healing in patients with wounds and chronic conditions. The upsurge in the prevalence of chronic ailments including neurological and cancer diseases is among the major factor that positively contributes toward the growth of the business. Other factors that enhance the industry expansion includes the rising elderly population and increasing malnutrition cases. The demand for enteral nutrition is growing significantly due to the inclusion of appropriate ingredients into the composition and improvements in the manufacturing techniques of the product.

The World Health Organization (WHO), in 2016, stated that there were rising number of children affected with malnutrition causing significant mortalities. Hence, various countries around the world are focused on improving the nutrition intake programs. For instance, in 2017, the Tanzania government announced the launch of the National Multi-sectoral Nutrition Action Plan to address issues with malnutrition in the country. Enteral nutrition is widely recommended for patients with chronic conditions in order to combat the weak immune system that affects the eating ability of an individual resulting in a drastic weight loss.

Browse key industry insights spread across 200 pages with 394 market data tables & 17 figures & charts from the report, “Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:

Rising investment by the market players to provide high quality enteral nutrition products will attract a large customer pool

The clinical nutrition market for adult segment is estimated to attain a CAGR of 7.5% CAGR by 2027 owing to the increasing awareness regarding chronic diseases, availability of advanced healthcare facilities, and favorable medical insurance policies. Adults with gastrointestinal disorders such as ulcerative colitis, short bowel syndrome, and bowel obstruction require enteral or parenteral nutrition. Hence, adoption of clinical nutrition in management of these diseases is poised to promote the segment growth. The increasing prevalence of gastrointestinal cancer is projected to boost the demand for medical nutrition among adult patients.

Growing concerns related to gastrointestinal disorders are anticipated to fuel the clinical nutrition market demand

The gastrointestinal disorders segment will reach over USD 20.2 billion by 2027 on account of the consistently rising elderly population suffering from gastrointestinal disorders including inflammatory bowel disease, intestinal obstruction, and constipation among others. Clinical nutrition and gut health are closely related, thus enteral & parenteral nutrition have a direct impact on the overall health and quality of life of a patient. For example, in India, the prevalence of functional gastrointestinal disorders is common in the rural population owing to the risk factors including disturbed sleep, anxiety, and chewing tobacco. The enteral and parenteral nutrition products play a key role in the treatment of critically ill patients with gut dysfunction. Thus, market participants are emphasizing on the expansion of their product and pipeline portfolio through partnerships with specialized companies in clinical nutrition.

Increasing number of pharmacies & drug stores are anticipated to accelerate the industry revenue

The pharmacies & drug stores in the clinical nutrition market are poised to expand at more than 7.9% CAGR through 2027 impelled by the easy accessibility, validation of prescriptions through licensed pharmacists, and quick processing time among others. As per the Drug Store News, pharmacy operations are becoming an increasingly important part of grocers’ business strategies that are expected to augment the industry demand significantly. The preference for pharmacies & drug stores is slated to surge due to the well-defined safety, easy availability of medicines, effective services, security policies, etc. The growing geriatric population is further fostering the segment expansion as they require appropriate physician prescribed clinical nutrition to address chronic ailments.

High product acceptance in China to curb the disease burden is set to spur the market growth

China accounted for majority of revenue share in the Asia Pacific clinical nutrition market and accounted for over USD 6 billion in 2020 driven by the increasing incidence of premature births and growing prevalence of the chronic disorders in the country. The major risk factors related to these premature births are diabetes, multiple pregnancies, alcohol consumption, and high blood pressure are presumed to boost the industry value. As per the published article, in 2016, the incidence of preterm birth was around 5.1% in China. Additionally, the prevalence of Parkinson’s diseases is estimated to reach 4.94 million by 2030 in China. The rising prevalence of metabolic disorders such as Hunter syndrome, Gaucher disease, and lactic acidosis are projected to propel the demand for clinical nutrition products in the country. Thus, with an emphasis of industry leaders on market development in China, the region will hold significant revenue in the global market.

Companies are focusing on strategies and launch of innovative products to expand customer base

Some of the major players operating in the clinical nutrition market are Abbott Laboratories, (Abbott Nutrition), Baxter International Inc., Fresenius Kabi, B Braun Melsungen AG, Mead Johnson (Reckitt Benckiser), Nestle Health Science, Perrigo, Pfizer Inc., and Danone among others.

Explore More on Related Topics:

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X